Original article by David Rogers
The Australian – Page: 13 & 20 : 12-Nov-20
Australia’s benchmark S&P/ASX 200 has gained 8.8 per cent so far in November, and it is now just 11.5 per cent shy of the record peak of 7,197.2 points in February. The market has been boosted by factors such as the outcome of the US presidential election and the encouraging initial clinical trial results for Pfizer’s coronavirus vaccine candidate. JP Morgan anticipates further upside for equities, forecasting that the global bull run is not yet over.
STANDARD AND POOR’S ASX 200 INDEX, JP MORGAN AND COMPANY INCORPORATED